Welcome to the vector analytics webinar hub
When you are developing viral or non-viral delivery platforms for vaccines, gene therapies, or phage-based treatments you need to apply the right technologies and expertise to ensure these delivery vectors help your treatments reach their full potential. Explore our webinars, where you’ll find insights, tips and advice from technology and application experts.
mRNA-LNP biophysical characterization bootcamp
Developing drugs as complex as mRNA-LNPs requires a customized analytical toolkit of methods and technologies. Join our expert team as we explore biophysical characterization for mRNA LNPs.
mRNA-LNP biophysical characterization bootcamp 2: How to run mRNA-LNP measurements on MicroCal PEAQ-DSC
Vector analytics masterclass
Join our team of characterization experts as they dive deep into the methodologies you need for successful vector development. They’ll also show you how to generate robust measurements and help you understand how a holistic approach to generating data analysis will give you greater confidence in your results.
Top tips for characterizing lipid nanoparticles: Vector analytics masterclass 1 of 6
Strategies for characterizing size and concentration of viral and non-viral vectors
An expert guide to using zeta potential for the surface characterization of viral and lipid-based vectors
How to use SEC-SLS and other detectors to understand mRNA vector composition
Discover how differential scanning calorimetry can help you improve the thermal stability of lipid-based vectors
Understanding lipid nanoparticles (LNPs)
Lipid nanoparticle characterization
Recent breakthroughs in mRNA-based vaccines highlight the potential of lipid-based particles as powerful and versatile delivery vectors for vaccines. But what characterization tools do you need to help you design, optimize and scale up nanoparticle production for mRNA-based vaccines?
Master Lipid Nanoparticle & Liposome Characterization with Light Scattering
Transform vaccine production with these nanoparticle characterization techniques
AAV formulation development: Extend serotype characterization with OMNISEC
Accelerate AAV Analysis with OMNISEC: viral titer and capsid empty/full ratios
Eliminate bottlenecks in biopharmaceutical characterization - OMNISEC reveals all
Streamline pharmaceutical development with advanced analytics
Finding fit-for-purpose analytics: AAV characterization and formulation development
Focus on vaccine development series
Discover the latest characterization tools that can be applied to virus and vaccine studies with insights from practicing experts in this four-part webinar series.